"May 20, 2011 -- The FDA has approved Edurant (rilpivirine) for use in anti-HIV drug cocktails.
In a head-to-head clinical trial, Edurant was as effective as the popular drug Sustiva (efavirenz). Edurant and Sustiva are in the class of"...
Some patients accidentally taking 600 mg twice daily have reported increased nervous system symptoms. One patient experienced involuntary muscle contractions.
Treatment of overdose with SUSTIVA should consist of general supportive measures, including monitoring of vital signs and observation of the patient's clinical status. Administration of activated charcoal may be used to aid removal of unabsorbed drug. There is no specific antidote for overdose with SUSTIVA. Since efavirenz is highly protein bound, dialysis is unlikely to significantly remove the drug from blood.
SUSTIVA is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product.
Last reviewed on RxList: 6/5/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Sustiva Information
Sustiva - User Reviews
Sustiva User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.